グリセリルグルコシド市場規模、シェア、動向、2031年までの世界予測

グリセリルグルコシド市場は、2026年の3,020万米ドルから2031年には3,900万米ドルに成長し、2026年から2031年までの年平均成長率は5.2%に達するとMarketsandMarketsでは予測しています。

グリセリルグルコシド市場は、2026年まで比較的ニッチなセグメントにとどまると予測されていますが、化粧品やパーソナルケア製品における高性能バイオベース保湿剤の需要の高まりにより、2031年まで着実な成長が見込まれています。市場は、高度な製品処方技術の採用、バイオテクノロジーベースの成分の開発、データ駆動型スキンケアソリューションの導入によって変革を遂げています。BASF SEやEvonik Industries AGといった主要企業は、この進化する市場に戦略的に注力しています。最近のイノベーションとしては、肌への浸透性を向上させ、長時間の保湿効果を提供し、クリーンラベルで持続可能な製品への需要を満たすように特別に配合された高純度グリセリルグルコシドが挙げられます。企業は、自然派化粧品や皮膚科用医薬品への消費者のトレンドに合わせて、バイオベースの生産技術やグリーンケミストリーへの投資をますます増やしています。その結果、高級皮膚科用化粧品や皮膚科用医薬品への消費者の関心の高まりなどが、高純度でプレミアムグレードのグリセリルグルコシド含有化粧品の需要を押し上げ、世界的な成長と用途拡大を支えると予想されます。

調査対象範囲：

世界のグリセリルグルコシド市場：種類別（モノグリセリルグルコシド、ジグリセリルグルコシド、トリグリセリル／高次グリコシド、混合グリコシド）、機能別（保湿剤、柔軟剤、テクスチャー改善剤、安定性向上剤、加工助剤、溶解性向上剤、その他）、用途別（パーソナルケア・化粧品、医薬品、食品・飲料、工業製品、その他）、形態別（液状溶液、粉末、配合混合物、その他）、原料別（天然、合成）濃度／有効成分含有量別（低濃度グレード：45%以下、中低濃度グレード：45～55%、中高濃度グレード：55～65%、高濃度グレード：65～85%以上）および地域別 – 2031年までの世界市場予測

本レポートでは、世界のグリセリルグルコシド市場の成長に影響を与える主要な要因（推進要因、阻害要因、課題、機会など）に関する詳細な情報を網羅しています。主要企業の詳細な分析を行い、事業概要、ソリューションとサービス、主要戦略、契約、パートナーシップ、協定に関する洞察を提供しています。また、世界のグリセリルグルコシド市場エコシステムにおける新興企業の競合分析も行っています。

本レポートを購入する理由：

• 本レポートは、グリセリルグルコシド市場全体および各サブセグメントの収益予測に関する最も正確な情報を提供することで、市場リーダーや新規参入企業を支援します。また、関係者が競争環境を理解し、より的確な事業展開と適切な市場参入戦略の策定に役立つ洞察を得るのに役立ちます。さらに、市場の動向を把握し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。
• 本レポートは、以下の点について洞察を提供します。
  タイプ、機能、最終用途産業、形態、供給源、濃度／有効成分に関する詳細なセグメンテーション：本調査では、主要な推進要因（高度なスキンケア成分への需要の高まり、保湿およびアンチエイジング製品への注目の高まり、バイオベースおよび特殊化学成分における研究開発とイノベーションの拡大、バイオベースおよび持続可能な成分への移行）、制約要因（高い生産および製剤コスト、中小規模メーカーにおける認知度の低さ、代替成分（例：ヒアルロン酸、グリセリン）の入手可能性）、機会（プレミアムおよび皮膚科スキンケア分野の拡大、アジア太平洋市場における需要の高まり、バイオ触媒および製剤技術のイノベーション、多機能化粧品における使用の拡大）、および課題（地域ごとの規制遵守、新興市場における価格感度、サプライチェーンおよび原材料への依存、既存の保湿成分との激しい競争）を検証します。
  新興市場に焦点を当てた地域別洞察：本レポートは、アジア太平洋地域における成長機会を強調し、国別および地域別の詳細な分析を提供します。北米、ヨーロッパ、ラテンアメリカ、中東・アフリカ地域を対象とし、地域ごとの需要パターン、灌漑普及率、グリセリルグルコシド関連の規制政策、グリセリルグルコシド市場への投資動向を評価し、事業拡大および現地化戦略に関するガイダンスを提供します。
• 競合情報とイノベーション状況：主要市場参加企業であるDeere & Company（米国）、AGCO Corporation（米国）、CNH Industrial N.V.（英国）、Väderstad AB（スウェーデン）、Kinze Manufacturing（米国）について詳細に分析しています。本レポートでは、世界のグリセリルグルコシド市場の競争力学を形成する、最近の製品発売、生産能力拡大、戦略的パートナーシップ、投資について取り上げています。
• データ駆動型手法に基づく需要予測：2031年までの市場規模と成長予測は、トップダウンとボトムアップのアプローチを組み合わせ、業界専門家、業界団体、政府公式データによって検証されています。これらの知見は、グローバルセクターにおける投資計画と市場機会評価のための信頼できる指針となります。

Report Description

The glyceryl glucoside market is projected to reach USD 39.0 million by 2031 from USD 30.2 million in 2026, at a CAGR of 5.2% from 2026 to 2031.

The glyceryl glucoside market is estimated to remain a relatively niche segment by 2026, with expectations of steady growth through 2031 due to a rising demand for high-performance, bio-based moisturizing agents in cosmetics and personal care applications. The market is witnessing a transformation driven by the adoption of advanced product formulation technologies, the development of biotechnology-based ingredients, and the implementation of data-driven skincare solutions. Key players such as BASF SE and Evonik Industries AG are focusing strategically on this evolving market. Recent innovations include specially formulated high-purity glyceryl glucosides designed to improve skin delivery, provide long-lasting hydration, and meet the demand for clean-label, sustainable products. Companies are increasingly investing in bio-based production techniques and green chemistry to align with the consumer trend towards natural cosmetics and dermaceuticals. Consequently, the growing consumer interest in “luxury” dermo-cosmetics and dermaceuticals, among other factors, is expected to drive the demand for high-purity and premium-grade cosmetics containing glyceryl glucosides, supporting consistent global growth and application.

Opportunities and disruptions: This market is closely tied to the increasing trend of personalized and clean beauty, showcasing significant growth potential for both cosmetics manufacturers and ingredient suppliers. For cosmetics companies, glyceryl glucoside enables the formulation of highly effective moisturizers, anti-aging products, and barrier-repair solutions, particularly in the premium skincare segment. Ingredient suppliers are presented with various opportunities to expand their product offerings by providing multifunctional and sustainable actives, developing application-specific formulations, and exploring biotech production. At the same time, the marketplace is undergoing substantial changes, highlighted by the swift adoption of biotech-based ingredients, stricter regulatory scrutiny of cosmetic formulations, and a consumer demand for transparency and sustainability. Additionally, market dynamics, such as the push for minimal and scientifically backed formulations, are significantly reshaping the competitive landscape.

AI-driven nutrient optimization: AI and machine learning are increasingly being used in the personal care and cosmetics industry to optimize ingredient blends, predict ingredient compatibility, and enhance performance claims. For instance, with glyceryl glucoside, these technologies enable targeted formulation development, improve efficacy testing, and accelerate innovation cycles.

Regarding advanced formulation technologies, the focus is on enhancing the stability, bioavailability, and overall performance of ingredients in complex cosmetic and personal care formulations. Processing technologies include microencapsulation, liposomal microencapsulation, and alternative delivery systems, often achieved through co-formulation with other active ingredients such as hyaluronic acid, peptides, and ceramides.

The natural segment is the leading category within the source segment of the glyceryl glucoside market.

This leadership can be attributed to the increasing consumer demand for bio-based and environmentally friendly ingredients in personal care and cosmetic products. Naturally derived glyceryl glucoside, typically produced from plant-sourced glucose and glycerol, aligns with consumers’ growing preference for healthy, eco-conscious, and composition-friendly cosmetic products. The strong adoption of this ingredient by premium cosmetic brands, coupled with the advocacy for green chemistry from regulatory bodies, has fueled the rapid growth of the natural segment. Additionally, heightened awareness regarding the health and environmental benefits of natural ingredients is encouraging manufacturers to shift toward renewable and biodegradable raw material sources.

In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the glyceryl glucoside market:

• By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30%
• By Designation: Directors – 20%, Managers – 50%, Executives – 30%
• By Region: North America – 25%, Europe – 30%, Asia Pacific – 20%, South America – 15%, and Rest of the World (Middle East and Africa) –10%

Prominent companies in the market include BASF SE (Germany), Evonik Industries AG (Germany), YR Chemspec (China), Beiersdorf AG (Germany), Puri Pharma (China), Storm Chemical (China), Incospharm (South Korea), Nanjing DASF Biotechnology Co., Ltd. (China), Seebio Biotech (Shanghai) Co., Ltd. (China), Woosung CNT Co., Ltd. (South Korea), Sino Lion Chemical Co., Ltd. (China), Soho Aneco Chemical Co., Ltd. (China), Creative Biogene (US), DKSH (Switzerland), and Shandong Zhishang Chemical (China).

Research Coverage:

Global Glyceryl Glucoside Market by Type (Mono-glyceryl Glucosides, Di-glyceryl Glucosides, Tri-glyceryl/Higher Glycosides, Mixed Glycosides); By Functionality (Humectants & Moisturizing Agents, Emollients & Conditioning Agents, Texture, Stability & Processing Aids, Solubility & Compatibility Enhancers, Others); By End-use Industry (Personal Care & Cosmetics, Pharmaceuticals, Food & Beverages, Industrial, Others); By Form (Liquid Solutions, Powder, Formulated Blends, Others); By Source (Natural, Synthetic); By Concentration/Active Content (Low-concentration Grades ≤45%, Mid-low Concentration Grades 45–55%, Mid-high Concentration Grades 55–65%, High-concentration Grades 65–85%+).and Region – Global Forecast to 2031

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the global glyceryl glucoside market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions and services, key strategies, contracts, partnerships, and agreements. Competitive analysis of upcoming startups in the global glyceryl glucoside market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue figures for the overall glyceryl glucoside market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

• In-depth Segmentation across Type, Functionality, End-use Industry, Form, Source and Concentration/ Active Content: The study examines key drivers (rising demand for advanced skincare ingredients, increasing focus on hydration and anti-aging products, growing R&D and innovation in bio-based and specialty chemical ingredients, shift toward bio-based and sustainable ingredients), restraints (high production and formulation costs, limited awareness among small and mid-scale manufacturers, availability of substitute ingredients (e.g., hyaluronic acid, glycerin)), opportunities (expansion in premium and dermatological skincare segments, rising demand in Asia Pacific markets, Innovation in bio-catalysis and formulation technologies, Growing use in multifunctional cosmetic products), and challenges (regulatory compliance across regions, price sensitivity in developing markets, supply chain and raw material dependency, strong competition from established moisturizing ingredients)
• Region-specific Insights with Focus on Emerging Markets: The report provides detailed country- and region-level analysis, highlighting growth opportunities across the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. It evaluates regional demand patterns, irrigation penetration, regulatory policies related to glyceryl glucoside, and investment trends in the glyceryl glucoside market, offering strategic guidance for expansion and localization initiatives.
• Competitive Intelligence and Innovation Landscape: Leading market participants, Deere & Company (US), AGCO Corporation (US), CNH Industrial N.V. (UK), Väderstad AB (Sweden), Kinze Manufacturing (US), are profiled in detail. The report covers recent product launches, capacity expansions, strategic partnerships, and investments shaping the competitive dynamics of the global glyceryl glucoside market.
• Demand Forecasts Backed by Data-driven Methodologies: Market sizing and growth projections through 2031 are developed using a combination of top-down and bottom-up approaches, validated by industry experts, trade associations, and official government data. These insights provide reliable guidance for investment planning and market opportunity assessment in the global sector.

Table of Contents

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 32
1.3 STUDY SCOPE 33
1.3.1 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 34
1.5 UNITS CONSIDERED 35
1.6 STAKEHOLDERS 35
1.7 SUMMARY OF CHANGES 36
1.8 RECESSION IMPACT 36
2 EXECUTIVE SUMMARY 37
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 37
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 39
2.3 DISRUPTIVE TRENDS IN GLYCERYL GLUCOSIDE MARKET 40
2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS 41
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 42
3 PREMIUM INSIGHTS 43
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN GLYCERYL GLUCOSIDE MARKET 43
3.2 GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION AND REGION 44
3.3 GLYCERYL GLUCOSIDE MARKET, BY SOURCE 44
3.4 GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY 45
3.5 GLYCERYL GLUCOSIDE MARKET, BY COUNTRY/REGION 45
4 MARKET OVERVIEW 46
4.1 INTRODUCTION 46
4.2 MARKET DYNAMICS 47
4.2.1 DRIVERS 47
4.2.1.1 Rising demand for advanced skincare ingredients 47
4.2.1.2 Increasing focus on hydration and anti-aging products 48
4.2.1.3 Growing R&D and innovation in bio-based and specialty chemical ingredients 49
4.2.1.4 Shift toward bio-based and sustainable ingredients 50
4.2.2 RESTRAINTS 51
4.2.2.1 High production and formulation costs 51
4.2.2.2 Limited awareness among small and mid-scale manufacturers 51
4.2.2.3 Availability of substitute ingredients 52
4.2.3 OPPORTUNITIES 53
4.2.3.1 Expansion in premium and dermatological skincare segments 53
4.2.3.2 Rising demand in Asia Pacific markets 53
4.2.3.3 Innovation in bio-catalysis and formulation technologies 54
4.2.3.4 Growing use in multifunctional cosmetic products 55
4.2.4 CHALLENGES 55
4.2.4.1 Regulatory compliance across regions 55
4.2.4.2 Price sensitivity in developing markets 56
4.2.4.3 Supply chain and raw material dependency 56
4.2.4.4 Strong competition from established moisturizing ingredients 57
4.3 UNMET NEEDS AND WHITE SPACES 57
4.3.1 UNMET NEEDS IN GLYCERYL GLUCOSIDE MARKET 57
4.3.2 WHITE SPACE OPPORTUNITIES 58
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 58
4.4.1 INTERCONNECTED MARKETS 58
4.4.2 CROSS-SECTOR OPPORTUNITIES 59
4.5 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS 59
4.5.1 EMERGING BUSINESS MODELS 59
4.5.2 ECOSYSTEM SHIFTS 60
4.6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 60
5 INDUSTRY TRENDS 61
5.1 PORTER’S FIVE FORCES ANALYSIS 61
5.1.1 THREAT OF NEW ENTRANTS 62
5.1.2 THREAT OF SUBSTITUTES 62
5.1.3 BARGAINING POWER OF SUPPLIERS 62
5.1.4 BARGAINING POWER OF BUYERS 62
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 63
5.2 MACROECONOMIC INDICATORS 63
5.2.1 RETAIL SALES INDICATOR FOR PERSONAL CARE MARKET DEMAND 63
5.2.2 RAW MATERIAL PRICE MOVEMENT INDICATOR FOR GLYCERYL GLUCOSIDE PRODUCTION COST STRUCTURE 64
5.3 VALUE CHAIN ANALYSIS 65
5.3.1 RAW MATERIAL SUPPLIERS 66
5.3.2 INTERMEDIATE PROCESSING & INGREDIENT MANUFACTURING 66
5.3.3 FORMULATION & PRODUCT DEVELOPMENT 67
5.3.4 CUSTOMIZATION & BRANDING 67
5.3.5 DISTRIBUTION & SUPPLY NETWORK 67
5.3.6 END USERS & POST-SALES SUPPORT 68
5.4 ECOSYSTEM ANALYSIS 68
5.4.1 DEMAND SIDE 68
5.4.2 SUPPLY SIDE 68
5.5 PRICING ANALYSIS 70
5.5.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONCENTRATION 70
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 71
5.5.3 AVERAGE SELLING PRICE TREND, BY FORM 72
5.6 TRADE ANALYSIS 73
5.6.1 EXPORT SCENARIO OF HS CODE 2938 73
5.6.2 IMPORT SCENARIO OF HS CODE 2938 74
5.7 KEY CONFERENCES AND EVENTS, 2026 76
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 76
5.9 CASE STUDY ANALYSIS 77
5.9.1 BASF SE LEVERAGES AI-DRIVEN FORMULATION PLATFORMS TO ACCELERATE BIO-BASED INGREDIENT INNOVATION 77
5.9.2 EVONIK INDUSTRIES AG UTILIZES AI AND COMPUTATIONAL BIOLOGY TO OPTIMIZE GLYCOSIDE PRODUCTION AND PERFORMANCE 78
5.9.3 BEIERSDORF AG APPLIES AI-POWERED SKIN RESEARCH TO ENHANCE EFFICACY OF ADVANCED SKINCARE INGREDIENTS 79
5.10 IMPACT OF 2026 US TARIFF – GLYCERYL GLUCOSIDE MARKET 79
5.10.1 INTRODUCTION 79
5.10.2 KEY TARIFF RATES 80
5.10.3 PRICE IMPACT ANALYSIS 80
5.10.4 IMPACT ON COUNTRIES/REGIONS 81
5.10.4.1 China (Asia Pacific) 81
5.10.4.2 European Union 81
5.10.4.3 South Korea 81
5.10.5 IMPACT ON END-USE INDUSTRIES 82
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 83
6.1 KEY EMERGING TECHNOLOGIES 83
6.1.1 ENZYMATIC BIOCATALYSIS & PRECISION FERMENTATION 83
6.1.2 ADVANCED PROCESS PATENTS FOR STABILITY & FUNCTIONAL ENHANCEMENT 83
6.1.3 AI-DRIVEN FORMULATION & INGREDIENT OPTIMIZATION 83
6.2 COMPLEMENTARY TECHNOLOGIES 84
6.2.1 MICROENCAPSULATION & CONTROLLED-RELEASE DELIVERY SYSTEMS 84
6.2.2 GREEN CHEMISTRY & BIO-BASED FEEDSTOCK INTEGRATION 84
6.2.3 MULTI-FUNCTIONAL ACTIVE BLENDING & SYNERGISTIC FORMULATION TECHNOLOGY 84
6.3 ADJACENT TECHNOLOGIES 85
6.3.1 SYNTHETIC BIOLOGY & METABOLIC PATHWAY ENGINEERING 85
6.3.2 SKIN MICROBIOME MODULATION & BIO-ACTIVE DELIVERY PLATFORMS 85
6.3.3 DIGITAL SKIN DIAGNOSTICS & PERSONALIZED SKINCARE PLATFORMS 85

6.4 TECHNOLOGY/PRODUCT ROADMAP 86
6.4.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 86
6.4.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 86
6.4.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 87
6.5 PATENT ANALYSIS 87
6.6 FUTURE APPLICATIONS 94
6.6.1 BIO-ENGINEERED HYDRATION ENHANCERS 94
6.6.2 AI-DRIVEN PERSONALIZED FORMULATIONS 95
6.6.3 ADVANCED ENCAPSULATION & DELIVERY SYSTEMS 95
6.6.4 MULTI-FUNCTIONAL INGREDIENT SYSTEMS 96
6.6.5 SUSTAINABLE BIO-BASED PRODUCTION 96
6.7 IMPACT OF GENERATIVE AI ON GLYCERYL GLUCOSIDE MARKET 97
6.7.1 INTRODUCTION 97
6.7.2 USE OF GENERATIVE AI ON GLYCERYL GLUCOSIDE MARKET 97
6.7.3 TOP USE CASES AND MARKET POTENTIAL 97
6.7.4 BEST PRACTICES IN GLYCERYL GLUCOSIDES INDUSTRY 98
6.7.5 CASE STUDIES OF AI IMPLEMENTATION IN GLYCERYL GLUCOSIDE MARKET 99
6.7.6 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 99
6.8 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN GLYCERYL GLUCOSIDE MARKET 100
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 102
7.1 REGIONAL REGULATIONS AND COMPLIANCE 102
7.1.1 INDUSTRY STANDARDS 108
7.2 SUSTAINABILITY INITIATIVES 111
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 111
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 112
7.4.1 REGION-WISE LABELING STANDARDS 112
7.4.1.1 North America 112
7.4.1.2 Europe 112
7.4.1.3 Asia Pacific 113
7.4.1.4 South America 113
7.4.1.5 Rest of the World (RoW) 114
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 115
8.1 DECISION-MAKING PROCESS 115
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 116
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 117
8.2.2 BUYING CRITERIA 117
8.3 ADOPTION BARRIER AND INTERNAL CHALLENGES 118
8.4 UNMET NEEDS OF VARIOUS END-USER/END-USE INDUSTRIES 119
8.4.1 PERSONAL CARE & COSMETICS INDUSTRY 119
8.4.2 DERMATOLOGY & PHARMACEUTICAL INDUSTRY 119
8.4.3 BIOTECHNOLOGY & LIFE SCIENCES INDUSTRY 119
8.4.4 FOOD & NUTRACEUTICAL INDUSTRY 120
8.5 MARKET PROFITABILITY 120
9 GLYCERYL GLUCOSIDE MARKET, BY TYPE 121
9.1 INTRODUCTION 122
9.2 MONO-GLYCERYL GLUCOSIDES 123
9.2.1 DRIVING VOLUME GROWTH THROUGH COST-EFFICIENT HYDRATION ACTIVES 123
9.3 DI-GLYCERYL GLUCOSIDES 125
9.3.1 PREMIUMIZATION LEVER THROUGH ENHANCED MOISTURE RETENTION AND BARRIER FUNCTIONALITY 125
9.4 TRI-GLYCERYL/HIGHER GLYCOSIDES 126
9.4.1 ADVANCING HIGH-PERFORMANCE ACTIVES FOR LONG-LASTING HYDRATION AND BARRIER ENGINEERING 126
9.5 MIXED GLYCOSIDES 128
9.5.1 OPTIMIZING FORMULATION FLEXIBILITY THROUGH MULTI-FUNCTIONAL GLYCOSIDE BLENDS 128
10 GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY 130
10.1 INTRODUCTION 131
10.2 HUMECTANTS & MOISTURIZING AGENTS 133
10.2.1 STRENGTHENING CORE DEMAND THROUGH BIOLOGICALLY ACTIVE HYDRATION SYSTEMS 133
10.3 EMOLLIENTS & CONDITIONING AGENTS 134
10.3.1 ENHANCING SENSORY PERFORMANCE AND BARRIER CONDITIONING IN ADVANCED FORMULATIONS 134
10.4 TEXTURE, STABILITY, & PROCESSING AIDS 136
10.4.1 ENABLING FORMULATION EFFICIENCY THROUGH MULTIFUNCTIONAL STABILIZATION SYSTEMS 136
10.5 SOLUBILITY & COMPATIBILITY ENHANCERS 137
10.5.1 FACILITATING ACTIVE INTEGRATION IN COMPLEX, MULTI-PHASE FORMULATIONS 137
10.6 OTHERS 139
11 GLYCERYL GLUCOSIDE MARKET, BY SOURCE 141
11.1 INTRODUCTION 142
11.2 NATURAL 143
11.2.1 DRIVING PREMIUM POSITIONING THROUGH BIO-BASED AND TRACEABLE INGREDIENT SYSTEMS 143
11.3 SYNTHETIC 145
11.3.1 ENSURING COST EFFICIENCY AND SCALABLE SUPPLY THROUGH CONTROLLED CHEMICAL SYNTHESIS 145

12 GLYCERYL GLUCOSIDE MARKET, BY FORM 148
12.1 INTRODUCTION 149
12.2 LIQUID SOLUTIONS 151
12.2.1 MAXIMIZING FORMULATION EFFICIENCY THROUGH READY-TO-USE AQUEOUS SYSTEMS 151
12.3 POWDER 152
12.3.1 ENABLING HIGH PURITY, CONCENTRATED FORMATS FOR PRECISION FORMULATION AND SUPPLY CHAIN EFFICIENCY 152
12.4 FORMULATED BLENDS & OTHERS 154
12.4.1 ACCELERATING TIME-TO-MARKET THROUGH PRE-OPTIMIZED MULTIFUNCTIONAL SYSTEMS 154
13 GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION 157
13.1 INTRODUCTION 158
13.2 LOW-CONCENTRATION GRADES (≤45%) 160
13.2.1 OPTIMIZING PERFORMANCE WITH LOW-CONCENTRATION GLYCERYL GLUCOSIDE SOLUTIONS 160
13.3 MID-LOW CONCENTRATION GRADES (45–55%) 162
13.3.1 ENHANCING FORMULATION EFFICIENCY WITH MID-LOW CONCENTRATION GLYCERYL GLUCOSIDE GRADES 162
13.4 MID-HIGH CONCENTRATION GRADES (55–65%) 164
13.4.1 MAXIMIZING FUNCTIONAL IMPACT WITH MID-HIGH CONCENTRATION GLYCERYL GLUCOSIDE GRADES 164
13.5 HIGH-CONCENTRATION GRADES (65–85%+) 166
13.5.1 DRIVING PREMIUM PERFORMANCE WITH HIGH-CONCENTRATION GLYCERYL GLUCOSIDE GRADES 166
14 GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY 169
14.1 INTRODUCTION 170
14.2 PERSONAL CARE & COSMETICS 172
14.2.1 ACCELERATING DEMAND THROUGH BIOACTIVE HYDRATION AND CLEAN-LABEL FORMULATIONS 172
14.3 PHARMACEUTICALS 174
14.3.1 EXPANDING UTILITY AS FUNCTIONAL EXCIPIENT IN DERMATOLOGICAL AND TOPICAL THERAPIES 174
14.4 FOOD & BEVERAGES 176
14.4.1 EXPLORING NICHE FUNCTIONAL ROLES IN CLEAN-LABEL AND STABILITY-DRIVEN FORMULATIONS 176
14.5 INDUSTRIAL & OTHERS 178
14.5.1 LEVERAGING PROCESS EFFICIENCY AND COMPATIBILITY IN SPECIALTY INDUSTRIAL APPLICATIONS 178

15 GLYCERYL GLUCOSIDE MARKET, BY REGION 181
15.1 INTRODUCTION 182
15.2 NORTH AMERICA 184
15.2.1 US 192
15.2.1.1 Demand for advanced dermaceutical innovation and premium skincare to drive market 192
15.2.2 CANADA 193
15.2.2.1 Clean beauty and regulatory-driven innovation to support glyceryl glucoside uptake 193
15.2.3 MEXICO 195
15.2.3.1 Expanding mid-market skincare and manufacturing base to drive glyceryl glucoside demand 195
15.3 EUROPE 196
15.3.1 GERMANY 204
15.3.1.1 Advanced chemical manufacturing and sustainable skincare innovation to drive market 204
15.3.2 FRANCE 205
15.3.2.1 Luxury skincare leadership and formulation excellence to drive market 205
15.3.3 UK 207
15.3.3.1 Science-backed skincare and regulatory transparency to drive market 207
15.3.4 ITALY 208
15.3.4.1 Premium formulation craftsmanship and natural ingredient integration to drive market 208
15.3.5 SPAIN 209
15.3.5.1 Growing dermo-cosmetic demand and export-oriented manufacturing to drive market 209
15.3.6 REST OF EUROPE 210
15.4 ASIA PACIFIC 212
15.4.1 CHINA 220
15.4.1.1 Technology-led skincare expansion and domestic manufacturing strength to drive market 220
15.4.2 INDIA 221
15.4.2.1 Rising domestic personal care demand and cost-effective formulation trends to drive market 221
15.4.3 JAPAN 223
15.4.3.1 Advanced skincare innovation and high-purity formulation standards to drive market 223
15.4.4 AUSTRALIA & NEW ZEALAND 224
15.4.4.1 Clean beauty leadership and premium skincare demand to drive market 224
15.4.5 SOUTH KOREA 226
15.4.5.1 Advanced K-beauty innovation and functional skincare leadership to drive market 226

15.4.6 INDONESIA 227
15.4.6.1 Expanding mass-market skincare and halal-compliant formulation trends to drive market 227
15.4.7 THAILAND 228
15.4.7.1 Growing dermo-cosmetic demand and tourism-driven skincare market to support glyceryl glucoside adoption 228
15.4.8 MALAYSIA 230
15.4.8.1 Southeast Asia export hub and clean beauty shift to drive glyceryl glucoside demand 230
15.4.9 VIETNAM 231
15.4.9.1 Emerging skincare market and rapid urbanization to drive glyceryl glucoside demand 231
15.4.10 PHILIPPINES 233
15.4.10.1 Rising mass-premium transition and climate-driven skincare needs to drive market 233
15.4.11 SINGAPORE 234
15.4.11.1 Regional innovation gateway and high-value skincare ecosystem to accelerate glyceryl glucoside demand 234
15.4.12 REST OF ASIA PACIFIC 235
15.5 SOUTH AMERICA 237
15.5.1 BRAZIL 244
15.5.1.1 Expanding local production and premium skincare development to drive market 244
15.5.2 ARGENTINA 245
15.5.2.1 Strengthening domestic formulation capabilities and import substitution to drive market 245
15.5.3 REST OF SOUTH AMERICA 246
15.6 REST OF THE WORLD 248
15.6.1 AFRICA 255
15.6.1.1 Gradual premiumization and climate-driven skincare need to support market growth 255
15.6.2 MIDDLE EAST 257
15.6.2.1 Premium skincare demand and climate-specific formulation needs to drive market 257
16 COMPETITIVE LANDSCAPE 259
16.1 OVERVIEW 259
16.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020–2025 260
16.3 REVENUE ANALYSIS, 2021–2025 261
16.4 MARKET SHARE ANALYSIS, 2025 261
16.4.1 BASF SE (GERMANY) 263
16.4.2 WOOSUNG CNT CO., LTD. (SOUTH KOREA) 263
16.4.3 BITOP AG (GERMANY) 263
16.5 PRODUCT COMPARISON 264

16.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 265
16.6.1 STARS 265
16.6.2 EMERGING LEADERS 265
16.6.3 PERVASIVE PLAYERS 265
16.6.4 PARTICIPANTS 265
16.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 267
16.6.5.1 Company footprint 267
16.6.5.2 Type footprint 268
16.6.5.3 Functionality footprint 269
16.6.5.4 End-use industry footprint 270
16.6.5.5 Source footprint 271
16.6.5.6 Form footprint 272
16.6.5.7 Concentration footprint 273
16.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 274
16.7.1 PROGRESSIVE COMPANIES 274
16.7.2 RESPONSIVE COMPANIES 274
16.7.3 DYNAMIC COMPANIES 274
16.7.4 STARTING BLOCKS 274
16.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 276
16.7.5.1 Detailed list of key startups/SMEs 276
16.7.5.2 Competitive benchmarking of key startups/SMEs 277
16.8 COMPETITIVE SCENARIO 278
16.8.1 DEALS 278
16.8.2 EXPANSIONS 278
17 COMPANY PROFILES 280
17.1 KEY PLAYERS 280
17.1.1 BASF SE 280
17.1.1.1 Business overview 280
17.1.1.2 Products offered 281
17.1.1.3 Recent developments 282
17.1.1.3.1 Deals 282
17.1.1.3.2 Expansions 282
17.1.1.4 MnM view 283
17.1.1.4.1 Key strengths 283
17.1.1.4.2 Strategic choices 283
17.1.1.4.3 Weaknesses and competitive threats 283
17.1.2 EVONIK INDUSTRIES AG 284
17.1.2.1 Business overview 284
17.1.2.2 Products offered 285
17.1.2.3 Recent developments 285
17.1.2.3.1 Deals 285
17.1.2.3.2 Expansions 285
17.1.2.3.3 Other developments 286
17.1.2.4 MnM view 286
17.1.2.4.1 Key strengths 286
17.1.2.4.2 Strategic choices 286
17.1.2.4.3 Weaknesses and competitive threats 286
17.1.3 YR CHEMSPEC 287
17.1.3.1 Business overview 287
17.1.3.2 Products offered 287
17.1.3.3 MnM view 288
17.1.3.3.1 Key strengths 288
17.1.3.3.2 Strategic choices 288
17.1.3.3.3 Weaknesses and competitive threats 288
17.1.4 BEIERSDORF AG 289
17.1.4.1 Business overview 289
17.1.4.2 Products offered 290
17.1.4.3 Recent developments 291
17.1.4.3.1 Deals 291
17.1.4.3.2 Expansions 291
17.1.4.3.3 Other developments 291
17.1.4.4 MnM view 292
17.1.4.4.1 Key strengths 292
17.1.4.4.2 Strategic choices 292
17.1.4.4.3 Weaknesses and competitive threats 292
17.1.5 PURI PHARMACEUTICAL CO., LTD 293
17.1.5.1 Business overview 293
17.1.5.2 Products offered 293
17.1.5.3 MnM view 294
17.1.5.3.1 Key strengths 294
17.1.5.3.2 Strategic choices 294
17.1.5.3.3 Weaknesses and competitive threats 294
17.1.6 STORM CORPORATION 295
17.1.6.1 Business overview 295
17.1.6.2 Products offered 295
17.1.6.3 MnM view 295
17.1.7 INCOSPHARM 296
17.1.7.1 Business overview 296
17.1.7.2 Products offered 296
17.1.7.3 MnM view 296
17.1.8 NANJING DASF BIOTECHNOLOGY CO., LTD. 297
17.1.8.1 Business overview 297
17.1.8.2 Products offered 297
17.1.8.3 MnM view 297
17.1.9 SEEBIO BIOTECH (SHANGHAI) CO., LTD 298
17.1.9.1 Business overview 298
17.1.9.2 Products offered 298
17.1.9.3 MnM view 298
17.1.10 WOOSUNG CNT CO., LTD. 299
17.1.10.1 Business overview 299
17.1.10.2 Products offered 299
17.1.10.3 MnM view 299
17.1.11 SINO LION CHEMICAL CO., LTD. 300
17.1.11.1 Business overview 300
17.1.11.2 Products offered 300
17.1.11.3 MnM view 300
17.1.12 SOHO ANECO CHEMICAL CO., LTD. 301
17.1.12.1 Business overview 301
17.1.12.2 Products offered 301
17.1.12.3 MnM view 301
17.1.13 CREATIVE BIOGENE 302
17.1.13.1 Business overview 302
17.1.13.2 Products offered 302
17.1.13.3 MnM view 302
17.1.14 DKSH 303
17.1.14.1 Business overview 303
17.1.14.2 Products offered 303
17.1.14.3 MnM view 303
17.1.15 SHANDONG ZHISHANG CHEMICAL CO., LTD. 304
17.1.15.1 Business overview 304
17.1.15.2 Products offered 304
17.1.15.3 MnM view 304
17.2 OTHER PLAYERS 305
17.2.1 GENECHEM 305
17.2.1.1 Business overview 305
17.2.1.2 Products offered 305
17.2.1.3 MnM view 305
17.2.2 ECSA CHEMICALS 306
17.2.2.1 Business overview 306
17.2.2.2 Products offered 306
17.2.2.3 MnM view 306
17.2.3 DADIA CHEMICAL INDUSTRIES 307
17.2.3.1 Business overview 307
17.2.3.2 Products offered 307
17.2.3.3 MnM view 308
17.2.4 GIHI CHEMICALS CO., LIMITED 309
17.2.4.1 Business overview 309
17.2.4.2 Products offered 309
17.2.4.3 MnM view 309
17.2.5 BIOTOP AG 310
17.2.5.1 Business overview 310
17.2.5.2 Products offered 310
17.2.5.3 MnM view 310
17.2.6 UNIPROMA 311
17.2.7 SUZHOU GREENWAY BIOTECH CO., LTD. 312
17.2.8 CHEMIPAN CORPORATION CO., LTD. 313
17.2.9 SUZHOU NMT BIOTECH 314
17.2.10 COSROMA 314
18 RESEARCH METHODOLOGY 315
18.1 RESEARCH DATA 315
18.1.1 SECONDARY DATA 316
18.1.1.1 List of major secondary sources 317
18.1.1.2 Key data from secondary sources 317
18.1.2 PRIMARY DATA 318
18.1.2.1 Key data from primary sources 318
18.1.2.2 Key industry insights 319
18.1.2.3 Breakdown of primaries 319
18.2 MARKET SIZE ESTIMATION 320
18.2.1 BOTTOM-UP APPROACH 320
18.2.2 TOP-DOWN APPROACH 322
18.2.2.1 Approach to estimate market size using top-down analysis 322
18.3 DATA TRIANGULATION 324
18.4 RESEARCH ASSUMPTIONS 325
18.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 325
19 ADJACENT AND RELATED MARKETS 326
19.1 INTRODUCTION 326
19.2 LIMITATIONS 326
19.3 FOOD EMULSIFIERS MARKET 326
19.3.1 MARKET DEFINITION 326
19.3.2 MARKET OVERVIEW 326

20 APPENDIX 328
20.1 DISCUSSION GUIDE 328
20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 333
20.3 CUSTOMIZATION OPTIONS 335
20.4 RELATED REPORTS 335
20.5 AUTHOR DETAILS 336

List of Tables

TABLE 1 INCLUSIONS AND EXCLUSIONS 32
TABLE 2 USD EXCHANGE RATES, 2021–2025 35
TABLE 3 KEY MOVES AND STRATEGIC FOCUS 60
TABLE 4 IMPACT OF PORTER’S FIVE FORCES ON GLYCERYL GLUCOSIDE MARKET 61
TABLE 5 ROLE OF COMPANIES IN ECOSYSTEM 70
TABLE 6 AVERAGE SELLING PRICE OF KEY PLAYER, BY CONCENTRATION, 2025 (USD/KG) 71
TABLE 7 AVERAGE SELLING PRICE TREND OF GLYCERYL GLUCOSIDE, BY REGION,
2023–2025 (USD/KG) 72
TABLE 8 AVERAGE SELLING PRICE TREND OF GLYCERYL GLUCOSIDE, BY FORM,
2023–2025 (USD/KG) 73
TABLE 9 EXPORT VALUE OF HS CODE 2938, BY KEY COUNTRY,
2021–2025 (USD THOUSAND) 74
TABLE 10 IMPORT VALUE OF HS CODE 2938, BY KEY COUNTRY,
2021–2025 (USD THOUSAND) 75
TABLE 11 GLYCERYL GLUCOSIDE MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026 76
TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES 80
TABLE 13 REGIONAL TARIFF IMPACT ON GLYCERYL GLUCOSIDE EXPORTS TO US 81
TABLE 14 KEY PATENTS PERTAINING TO GLYCERYL GLUCOSIDE, 2016–2025 88
TABLE 15 TOP USE CASES AND MARKET POTENTIAL 97
TABLE 16 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 98
TABLE 17 GLYCERYL GLUCOSIDE MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 99
TABLE 18 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 99
TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105
TABLE 22 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 23 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107
TABLE 24 GLOBAL INDUSTRY STANDARDS IN GLYCERYL GLUCOSIDE MARKET 109
TABLE 25 KEY INDUSTRY STANDARDS FOR GLYCERYL GLUCOSIDE MARKET 110
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR SOURCES 117
TABLE 27 KEY BUYING CRITERIA FOR SOURCES 118
TABLE 28 GLYCERYL GLUCOSIDE MARKET, BY TYPE, 2021–2025 (USD MILLION) 123
TABLE 29 GLYCERYL GLUCOSIDE MARKET, BY TYPE, 2026–2031 (USD MILLION) 123
TABLE 30 MONO-GLYCERYL GLUCOSIDES: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (USD MILLION) 124
TABLE 31 MONO-GLYCERYL GLUCOSIDES: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (USD MILLION) 125
TABLE 32 DI-GLYCERYL GLUCOSIDES: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 126
TABLE 33 DI-GLYCERYL GLUCOSIDES: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 126
TABLE 34 TRI-GLYCERYL/HIGHER GLYCOSIDES: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (USD MILLION) 127
TABLE 35 TRI-GLYCERYL/HIGHER GLYCOSIDES: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (USD MILLION) 128
TABLE 36 MIXED GLYCOSIDES: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 129
TABLE 37 MIXED GLYCOSIDES: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 129
TABLE 38 GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY, 2021–2025 (USD MILLION) 132
TABLE 39 GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY, 2026–2031 (USD MILLION) 132
TABLE 40 HUMECTANTS & MOISTURIZING AGENTS: GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2021–2025 (USD MILLION) 134
TABLE 41 HUMECTANTS & MOISTURIZING AGENTS: GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2026–2031 (USD MILLION) 134
TABLE 42 EMOLLIENTS & CONDITIONING AGENTS: GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2021–2025 (USD MILLION) 135
TABLE 43 EMOLLIENTS & CONDITIONING AGENTS: GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2026–2031 (USD MILLION) 135
TABLE 44 TEXTURE, STABILITY, & PROCESSING AIDS: GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2021–2025 (USD MILLION) 137
TABLE 45 TEXTURE, STABILITY, & PROCESSING AIDS: GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2026–2031 (USD MILLION) 137
TABLE 46 SOLUBILITY & COMPATIBILITY ENHANCERS: GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2021–2025 (USD MILLION) 138
TABLE 47 SOLUBILITY & COMPATIBILITY ENHANCERS: GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2026–2031 (USD MILLION) 138
TABLE 48 OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (USD MILLION) 139
TABLE 49 OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (USD MILLION) 140
TABLE 50 GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2021–2025 (USD MILLION) 143
TABLE 51 GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2026–2031 (USD MILLION) 143
TABLE 52 NATURAL: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 144
TABLE 53 NATURAL: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 144
TABLE 54 NATURAL: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (MT) 145
TABLE 55 NATURAL: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (MT) 145
TABLE 56 SYNTHETIC: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 146
TABLE 57 SYNTHETIC: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 146
TABLE 58 SYNTHETIC: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (MT) 146
TABLE 59 SYNTHETIC: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (MT) 147
TABLE 60 GLYCERYL GLUCOSIDE MARKET, BY FORM, 2021–2025 (USD MILLION) 150
TABLE 61 GLYCERYL GLUCOSIDE MARKET, BY FORM, 2026–2031 (USD MILLION) 150
TABLE 62 GLYCERYL GLUCOSIDE MARKET, BY FORM, 2021–2025 (MT) 150
TABLE 63 GLYCERYL GLUCOSIDE MARKET, BY FORM, 2026–2031 (MT) 150
TABLE 64 LIQUID SOLUTIONS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 151
TABLE 65 LIQUID SOLUTIONS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 152
TABLE 66 LIQUID SOLUTIONS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (MT) 152
TABLE 67 LIQUID SOLUTIONS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (MT) 152
TABLE 68 POWDER: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 153
TABLE 69 POWDER: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 153
TABLE 70 POWDER: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (MT) 154
TABLE 71 POWDER: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (MT) 154
TABLE 72 FORMULATED BLENDS & OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (USD MILLION) 155
TABLE 73 FORMULATED BLENDS & OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (USD MILLION) 155
TABLE 74 FORMULATED BLENDS & OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (MT) 156
TABLE 75 FORMULATED BLENDS & OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (MT) 156
TABLE 76 GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2021–2025 (USD MILLION) 159
TABLE 77 GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2026–2031 (USD MILLION) 159
TABLE 78 GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2021–2025 (MT) 160
TABLE 79 GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2026–2031 (MT) 160
TABLE 80 LOW-CONCENTRATION GRADES (<45%): GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2021–2025 (USD MILLION) 161
TABLE 81 LOW-CONCENTRATION GRADES (<45%): GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2026–2031 (USD MILLION) 161
TABLE 82 LOW-CONCENTRATION GRADES (<45%): GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2021–2025 (MT) 161
TABLE 83 LOW-CONCENTRATION GRADES (<45%): GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2026–2031 (MT) 162
TABLE 84 MID-LOW CONCENTRATION GRADES (45–55%), BY REGION,
2021–2025 (USD MILLION) 163
TABLE 85 MID-LOW CONCENTRATION GRADES (45–55%), BY REGION,
2026–2031 (USD MILLION) 163
TABLE 86 MID-LOW CONCENTRATION GRADES (45–55%), BY REGION, 2021–2025 (MT) 163
TABLE 87 MID-LOW CONCENTRATION GRADES (45–55%), BY REGION, 2026–2031 (MT) 164
TABLE 88 MID-HIGH CONCENTRATION GRADES (55–65%): GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (USD MILLION) 165
TABLE 89 MID-HIGH CONCENTRATION GRADES (55–65%): GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (USD MILLION) 165
TABLE 90 MID-HIGH CONCENTRATION GRADES (55–65%): GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (MT) 166
TABLE 91 MID-HIGH CONCENTRATION GRADES (55–65%): GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (MT) 166
TABLE 92 HIGH-CONCENTRATION GRADES (65–85%+): GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2021–2025 (USD MILLION) 167
TABLE 93 HIGH-CONCENTRATION GRADES (65–85%+): GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2026–2031 (USD MILLION) 167
TABLE 94 HIGH-CONCENTRATION GRADES (65–85%+): GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2021–2025 (MT) 168
TABLE 95 HIGH-CONCENTRATION GRADES (65–85%+): GLYCERYL GLUCOSIDE MARKET,
BY REGION, 2026–2031 (MT) 168
TABLE 96 GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 171
TABLE 97 GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 171
TABLE 98 GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2021–2025 (MT) 172
TABLE 99 GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2026–2031 (MT) 172
TABLE 100 PERSONAL CARE & COSMETICS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (USD MILLION) 173
TABLE 101 PERSONAL CARE & COSMETICS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (USD MILLION) 173
TABLE 102 PERSONAL CARE & COSMETICS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (MT) 174
TABLE 103 PERSONAL CARE & COSMETICS: GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (MT) 174
TABLE 104 PHARMACEUTICALS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 175
TABLE 105 PHARMACEUTICALS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 175
TABLE 106 PHARMACEUTICALS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (MT) 176
TABLE 107 PHARMACEUTICALS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (MT) 176
TABLE 108 FOOD & BEVERAGES: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 177
TABLE 109 FOOD & BEVERAGES: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 177
TABLE 110 FOOD & BEVERAGES: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (MT) 178
TABLE 111 FOOD & BEVERAGES: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (MT) 178
TABLE 112 INDUSTRIAL & OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 179
TABLE 113 INDUSTRIAL & OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 179
TABLE 114 INDUSTRIAL & OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (MT) 180
TABLE 115 INDUSTRIAL & OTHERS: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (MT) 180
TABLE 116 GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (USD MILLION) 183
TABLE 117 GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (USD MILLION) 183
TABLE 118 GLYCERYL GLUCOSIDE MARKET, BY REGION, 2021–2025 (MT) 184
TABLE 119 GLYCERYL GLUCOSIDE MARKET, BY REGION, 2026–2031 (MT) 184
TABLE 120 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY,
2021–2025 (USD MILLION) 185
TABLE 121 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 185
TABLE 122 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY, 2021–2025 (MT) 185
TABLE 123 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY, 2026–2031 (MT) 186
TABLE 124 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 186
TABLE 125 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 186
TABLE 126 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (MT) 186
TABLE 127 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (MT) 187
TABLE 128 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY TYPE,
2021–2025 (USD MILLION) 187
TABLE 129 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY TYPE,
2026–2031 (USD MILLION) 187
TABLE 130 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2021–2025 (USD MILLION) 188
TABLE 131 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2026–2031 (USD MILLION) 188
TABLE 132 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2021–2025 (USD MILLION) 188
TABLE 133 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2026–2031 (USD MILLION) 189
TABLE 134 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2021–2025 (MT) 189
TABLE 135 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2026–2031 (MT) 189
TABLE 136 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2021–2025 (USD MILLION) 189
TABLE 137 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2026–2031 (USD MILLION) 189
TABLE 138 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2021–2025 (MT) 190
TABLE 139 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2026–2031 (MT) 190
TABLE 140 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2021–2025 (USD MILLION) 190
TABLE 141 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2026–2031 (USD MILLION) 190
TABLE 142 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2021–2025 (MT) 191
TABLE 143 NORTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2026–2031 (MT) 191
TABLE 144 US: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 193
TABLE 145 US: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 193
TABLE 146 CANADA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 194
TABLE 147 CANADA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 194
TABLE 148 MEXICO: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 196
TABLE 149 MEXICO: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 196
TABLE 150 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY,
2021–2025 (USD MILLION) 197
TABLE 151 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 198
TABLE 152 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY, 2021–2025 (KT) 198
TABLE 153 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY, 2026–2031 (KT) 198
TABLE 154 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 199
TABLE 155 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 199
TABLE 156 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (MT) 199
TABLE 157 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (MT) 199
TABLE 158 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY TYPE, 2021–2025 (USD MILLION) 200
TABLE 159 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY TYPE, 2026–2031 (USD MILLION) 200
TABLE 160 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2021–2025 (USD MILLION) 200
TABLE 161 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2026–2031 (USD MILLION) 201
TABLE 162 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2021–2025 (USD MILLION) 201
TABLE 163 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2026–2031 (USD MILLION) 201
TABLE 164 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2021–2025 (MT) 201
TABLE 165 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2026–2031 (MT) 202
TABLE 166 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2021–2025 (USD MILLION) 202
TABLE 167 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2026–2031 (USD MILLION) 202
TABLE 168 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2021–2025 (MT) 202
TABLE 169 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2026–2031 (MT) 203
TABLE 170 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2021–2025 (USD MILLION) 203
TABLE 171 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2026–2031 (USD MILLION) 203
TABLE 172 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2021–2025 (MT) 203
TABLE 173 EUROPE: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2026–2031 (MT) 204
TABLE 174 GERMANY: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 205
TABLE 175 GERMANY: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 205
TABLE 176 FRANCE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 206
TABLE 177 FRANCE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 206
TABLE 178 UK: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 207
TABLE 179 UK: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 208
TABLE 180 ITALY: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 209
TABLE 181 ITALY: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 209
TABLE 182 SPAIN: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 210
TABLE 183 SPAIN: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 210
TABLE 184 REST OF EUROPE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 211
TABLE 185 REST OF EUROPE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 212
TABLE 186 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY,
2021–2025 (USD MILLION) 213
TABLE 187 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 214
TABLE 188 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY, 2021–2025 (KT) 214
TABLE 189 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY, 2026–2031 (KT) 215
TABLE 190 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 215
TABLE 191 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 215
TABLE 192 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (MT) 216
TABLE 193 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (MT) 216
TABLE 194 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY TYPE,
2021–2025 (USD MILLION) 216
TABLE 195 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY TYPE,
2026–2031 (USD MILLION) 216
TABLE 196 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2021–2025 (USD MILLION) 217
TABLE 197 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2026–2031 (USD MILLION) 217
TABLE 198 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2021–2025 (USD MILLION) 217
TABLE 199 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2026–2031 (USD MILLION) 217
TABLE 200 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2021–2025 (MT) 218
TABLE 201 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2026–2031 (MT) 218
TABLE 202 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2021–2025 (USD MILLION) 218
TABLE 203 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2026–2031 (USD MILLION) 218
TABLE 204 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2021–2025 (MT) 218
TABLE 205 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2026–2031 (MT) 219
TABLE 206 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2021–2025 (USD MILLION) 219
TABLE 207 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2026–2031 (USD MILLION) 219
TABLE 208 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2021–2025 (MT) 219
TABLE 209 ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2026–2031 (MT) 220
TABLE 210 CHINA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 221
TABLE 211 CHINA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 221
TABLE 212 INDIA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 222
TABLE 213 INDIA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 222
TABLE 214 JAPAN: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 224
TABLE 215 JAPAN: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 224
TABLE 216 AUSTRALIA & NEW ZEALAND: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2021–2025 (USD MILLION) 225
TABLE 217 AUSTRALIA & NEW ZEALAND: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION) 225
TABLE 218 SOUTH KOREA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 227
TABLE 219 SOUTH KOREA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 227
TABLE 220 INDONESIA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 228
TABLE 221 INDONESIA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 228
TABLE 222 THAILAND: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 229
TABLE 223 THAILAND: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 230
TABLE 224 MALAYSIA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 231
TABLE 225 MALAYSIA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 231
TABLE 226 VIETNAM: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 232
TABLE 227 VIETNAM: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 232
TABLE 228 PHILIPPINES: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 234
TABLE 229 PHILIPPINES: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 234
TABLE 230 SINGAPORE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 235
TABLE 231 SINGAPORE: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 235
TABLE 232 REST OF ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2021–2025 (USD MILLION) 236
TABLE 233 REST OF ASIA PACIFIC: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION) 236
TABLE 234 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY,
2021–2025 (USD MILLION) 237
TABLE 235 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 238
TABLE 236 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY, 2021–2025 (MT) 238
TABLE 237 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY COUNTRY, 2026–2031 (MT) 238
TABLE 238 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 238
TABLE 239 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 239
TABLE 240 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (MT) 239
TABLE 241 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (MT) 239
TABLE 242 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY TYPE,
2021–2025 (USD MILLION) 240
TABLE 243 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY TYPE,
2026–2031 (USD MILLION) 240
TABLE 244 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2021–2025 (USD MILLION) 240
TABLE 245 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2026–2031 (USD MILLION) 241
TABLE 246 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2021–2025 (USD MILLION) 241
TABLE 247 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2026–2031 (USD MILLION) 241
TABLE 248 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2021–2025 (MT) 241
TABLE 249 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY SOURCE, 2026–2031 (MT) 242
TABLE 250 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2021–2025 (USD MILLION) 242
TABLE 251 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2026–2031 (USD MILLION) 242
TABLE 252 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2021–2025 (MT) 242
TABLE 253 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY FORM, 2026–2031 (MT) 243
TABLE 254 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2021–2025 (USD MILLION) 243
TABLE 255 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2026–2031 (USD MILLION) 243
TABLE 256 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2021–2025 (MT) 243
TABLE 257 SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION,
2026–2031 (MT) 244
TABLE 258 BRAZIL: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 245
TABLE 259 BRAZIL: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 245
TABLE 260 ARGENTINA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 246
TABLE 261 ARGENTINA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 246
TABLE 262 REST OF SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2021–2025 (USD MILLION) 247
TABLE 263 REST OF SOUTH AMERICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION) 248
TABLE 264 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (USD MILLION) 249
TABLE 265 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (USD MILLION) 249
TABLE 266 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2021–2025 (MT) 249
TABLE 267 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY REGION,
2026–2031 (MT) 249
TABLE 268 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2021–2025 (USD MILLION) 250
TABLE 269 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2026–2031 (USD MILLION) 250
TABLE 270 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2021–2025 (MT) 250
TABLE 271 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY, 2026–2031 (MT) 251
TABLE 272 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY TYPE,
2021–2025 (USD MILLION) 251
TABLE 273 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY TYPE,
2026–2031 (USD MILLION) 251
TABLE 274 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2021–2025 (USD MILLION) 252
TABLE 275 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY FUNCTIONALITY,
2026–2031 (USD MILLION) 252
TABLE 276 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2021–2025 (USD MILLION) 252
TABLE 277 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2026–2031 (USD MILLION) 253
TABLE 278 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2021–2025 (MT) 253
TABLE 279 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY SOURCE,
2026–2031 (MT) 253
TABLE 280 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2021–2025 (USD MILLION) 253
TABLE 281 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2026–2031 (USD MILLION) 254
TABLE 282 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2021–2025 (MT) 254
TABLE 283 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY FORM,
2026–2031 (MT) 254
TABLE 284 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2021–2025 (USD MILLION) 254
TABLE 285 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2026–2031 (USD MILLION) 255
TABLE 286 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2021–2025 (MT) 255
TABLE 287 REST OF THE WORLD: GLYCERYL GLUCOSIDE MARKET, BY CONCENTRATION, 2026–2031 (MT) 255
TABLE 288 AFRICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 256
TABLE 289 AFRICA: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 257
TABLE 290 MIDDLE EAST: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2021–2025 (USD MILLION) 258
TABLE 291 MIDDLE EAST: GLYCERYL GLUCOSIDE MARKET, BY END-USE INDUSTRY,
2026–2031 (USD MILLION) 258
TABLE 292 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GLYCERYL
GLUCOSIDE MARKET, 2020–2025 260
TABLE 293 GLYCERYL GLUCOSIDE MARKET: DEGREE OF COMPETITION 262
TABLE 294 GLYCERYL GLUCOSIDE MARKET: TYPE FOOTPRINT 268
TABLE 295 GLYCERYL GLUCOSIDE MARKET: FUNCTIONALITY FOOTPRINT 269
TABLE 296 GLYCERYL GLUCOSIDE MARKET: END-USE INDUSTRY FOOTPRINT 270
TABLE 297 GLYCERYL GLUCOSIDE MARKET: SOURCE FOOTPRINT 271
TABLE 298 GLYCERYL GLUCOSIDE MARKET: FORM FOOTPRINT 272
TABLE 299 GLYCERYL GLUCOSIDE MARKET: CONCENTRATION FOOTPRINT 273
TABLE 300 GLYCERYL GLUCOSIDE MARKET: KEY STARTUPS/SMES 276
TABLE 301 GLYCERYL GLUCOSIDE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025 277
TABLE 302 GLYCERYL GLUCOSIDE MARKET: DEALS, JANUARY 2021–DECEMBER 2025 278
TABLE 303 GLYCERYL GLUCOSIDE MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2025 278
TABLE 304 BASF SE: COMPANY OVERVIEW 280
TABLE 305 BASF SE: PRODUCTS OFFERED 281
TABLE 306 BASF SE: DEALS 282
TABLE 307 BASF SE: EXPANSIONS 282
TABLE 308 EVONIK INDUSTRIES AG: COMPANY OVERVIEW 284
TABLE 309 EVONIK INDUSTRIES AG: PRODUCTS OFFERED 285
TABLE 310 EVONIK INDUSTRIES AG: DEALS 285
TABLE 311 EVONIK INDUSTRIES AG: EXPANSIONS 285
TABLE 312 EVONIK INDUSTRIES AG: OTHER DEVELOPMENTS 286
TABLE 313 YR CHEMSPEC: COMPANY OVERVIEW 287
TABLE 314 YR CHEMSPEC: PRODUCTS OFFERED 287
TABLE 315 BEIERSDORF AG : COMPANY OVERVIEW 289
TABLE 316 BEIERSDORF AG: PRODUCTS OFFERED 290
TABLE 317 BEIERSDORF AG: DEALS 291
TABLE 318 BEIERSDORF AG: EXPANSIONS 291
TABLE 319 BEIERSDORF AG: OTHER DEVELOPMENTS 291
TABLE 320 PURI PHARMACEUTICAL CO., LTD: COMPANY OVERVIEW 293
TABLE 321 PURI PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED 293
TABLE 322 STORM CORPORATION: COMPANY OVERVIEW 295
TABLE 323 STORM CORPORATION: PRODUCTS OFFERED 295
TABLE 324 INCOSPHARM: COMPANY OVERVIEW 296
TABLE 325 INCOSPHARM: PRODUCTS OFFERED 296
TABLE 326 NANJING DASF BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 297
TABLE 327 NANJING DASF BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 297
TABLE 328 SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW 298
TABLE 329 SEEBIO BIOTECH (SHANGHAI) CO., LTD.: PRODUCTS OFFERED 298
TABLE 330 WOOSUNG CNT CO., LTD.: COMPANY OVERVIEW 299
TABLE 331 WOOSUNG CNT CO., LTD.: PRODUCTS OFFERED 299
TABLE 332 SINO LION CHEMICAL CO., LTD.: COMPANY OVERVIEW 300
TABLE 333 SINO LION CHEMICAL CO., LTD.: PRODUCTS OFFERED 300
TABLE 334 SOHO ANECO CHEMICAL CO., LTD.: COMPANY OVERVIEW 301
TABLE 335 SOHO ANECO CHEMICAL CO., LTD.: PRODUCTS OFFERED 301
TABLE 336 CREATIVE BIOGENE: COMPANY OVERVIEW 302
TABLE 337 CREATIVE BIOGENE: PRODUCTS OFFERED 302
TABLE 338 DKSH: COMPANY OVERVIEW 303
TABLE 339 DKSH: PRODUCTS OFFERED 303
TABLE 340 SHANDONG ZHISHANG CHEMICAL CO., LTD.: COMPANY OVERVIEW 304
TABLE 341 SHANDONG ZHISHANG CHEMICAL CO., LTD.: PRODUCTS OFFERED 304
TABLE 342 GENECHEM: COMPANY OVERVIEW 305
TABLE 343 GENE CHEM: PRODUCTS OFFERED 305
TABLE 344 ECSA CHEMICALS: COMPANY OVERVIEW 306
TABLE 345 ECSA CHEMICALS: PRODUCTS OFFERED 306
TABLE 346 DADIA CHEMICAL INDUSTRIES: COMPANY OVERVIEW 307
TABLE 347 DADIA CHEMICAL INDUSTRIES: PRODUCTS OFFERED 307
TABLE 348 GIHI CHEMICALS CO., LIMITED: COMPANY OVERVIEW 309
TABLE 349 GIHI CHEMICALS CO., LIMITED: PRODUCTS OFFERED 309
TABLE 350 BIOTOP AG: COMPANY OVERVIEW 310
TABLE 351 BIOTOP AG: PRODUCTS OFFERED 310
TABLE 352 UNIPROMA: COMPANY OVERVIEW 311
TABLE 353 SUZHOU GREENWAY BIOTECH CO., LTD.: COMPANY OVERVIEW 312
TABLE 354 CHEMIPAN CORPORATION CO., LTD.: COMPANY OVERVIEW 313
TABLE 355 SUZHOU NMT BIOTECH: COMPANY OVERVIEW 314
TABLE 356 COSROMA: COMPANY OVERVIEW 314
TABLE 357 ADJACENT MARKET 326
TABLE 358 FOOD EMULSIFIERS MARKET, BY SOURCE, 2018–2022 (USD MILLION) 327
TABLE 359 FOOD EMULSIFIERS MARKET, BY SOURCE, 2023–2028 (USD MILLION) 327

List of Figures

FIGURE 1 MARKET SEGMENTATION 33
FIGURE 2 MARKET HIGHLIGHTS AND KEY INSIGHTS 37
FIGURE 3 GLYCERYL GLUCOSIDE MARKET, 2021–2031 38
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN GLYCERYL GLUCOSIDE MARKET, 2021–2025 39
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF GLYCERYL GLUCOSIDE MARKET 40
FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN GLYCERYL GLUCOSIDE MARKET, 2026–2031 41
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 42
FIGURE 8 RISING DEMAND FOR CLEAN-LABEL AND BIO-BASED SKINCARE INGREDIENTS IN GLYCERYL GLUCOSIDE MARKET 43
FIGURE 9 MID-HIGH (55-65%) SEGMENT AND ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026 44
FIGURE 10 NATURAL SEGMENT TO DOMINATE MARKET IN 2026 44
FIGURE 11 HUMECTANTS & MOISTURIZING AGENTS SEGMENT TO
DOMINATE MARKET IN 2026 45
FIGURE 12 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 45
FIGURE 13 GLYCERYL GLUCOSIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 47
FIGURE 14 EUROPE COSMETIC AND PERSONAL CARE INDUSTRY, BY COUNTRY, 2024 48
FIGURE 15 GROWTH IN RESEARCH AND INNOVATION FOR BIO-BASED BEAUTY
INGREDIENTS, 2013–2023 50
FIGURE 16 HIGH-GROWTH PROSPECT REGIONS FOR BEAUTY AND PERSONAL CARE MARKET 54
FIGURE 17 GLYCERYL GLUCOSIDE MARKET: PORTER’S FIVE FORCES ANALYSIS 61
FIGURE 18 US HEALTH AND PERSONAL CARE RETAIL SALES 64
FIGURE 19 RAW MATERIAL PRICE MOVEMENT INDICATOR, 2023–2025 65
FIGURE 20 GLYCERYL GLUCOSIDE MARKET: VALUE CHAIN ANALYSIS 66
FIGURE 21 KEY PARTICIPANTS IN GLYCERYL GLUCOSIDE ECOSYSTEM 69
FIGURE 22 GLYCERYL GLUCOSIDE MARKET: ECOSYSTEM ANALYSIS 69
FIGURE 23 AVERAGE SELLING PRICE TREND OF GLYCERYL GLUCOSIDE, BY REGION,
2023–2025 (USD/KG) 71
FIGURE 24 AVERAGE SELLING PRICE TREND OF GLYCERYL GLUCOSIDE, BY FORM,
2023–2025 (USD/KG) 72
FIGURE 25 EXPORT VALUE OF HS CODE 2938, BY KEY COUNTRY,
2021–2025 (USD THOUSAND) 73
FIGURE 26 IMPORT VALUE OF HS CODE 2938, BY KEY COUNTRY,
2021–2025 (USD THOUSAND) 75
FIGURE 27 GLYCERYL GLUCOSIDE MARKET: TRENDS/DISRUPTIONS IMPACTING
CUSTOMER BUSINESS 77
FIGURE 28 NUMBER OF PATENTS APPLIED AND GRANTED 2016-2026 88
FIGURE 29 FUTURE APPLICATIONS 94
FIGURE 30 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 101
FIGURE 31 GLYCERYL GLUCOSIDE MARKET: DECISION-MAKING FACTORS 116
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR SOURCES 117
FIGURE 33 KEY INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR SOURCES 118
FIGURE 34 MONO-GLYCERYL GLUCOSIDES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 123
FIGURE 35 HUMECTANTS & MOISTURIZING AGENTS SEGMENT TO LEAD MARKET
FROM 2026 TO 2031 132
FIGURE 36 NATURAL SEGMENT TO LEAD MARKET FROM 2026 TO 2031 143
FIGURE 37 LIQUID SOLUTIONS SEGMENT TO DOMINATE MARKET FROM 2026 TO 2031 149
FIGURE 38 MID-HIGH (55–65%) SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 159
FIGURE 39 PERSONAL CARE & COSMETICS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 171
FIGURE 40 INDIA TO BE THE FASTEST-GROWING MARKET DURING FORECAST PERIOD 183
FIGURE 41 ASIA PACIFIC: MARKET SNAPSHOT 213
FIGURE 42 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD BILLION) 261
FIGURE 43 SHARE ANALYSIS OF KEY PLAYERS IN GLYCERYL GLUCOSIDE MARKET, 2025 262
FIGURE 44 GLYCERYL GLUCOSIDE MARKET: PRODUCT ANALYSIS OF KEY PLAYERS 264
FIGURE 45 GLYCERYL GLUCOSIDE MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 266
FIGURE 46 GLYCERYL GLUCOSIDE MARKET: COMPANY FOOTPRINT 267
FIGURE 47 GLYCERYL GLUCOSIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 275
FIGURE 48 BASF SE: COMPANY SNAPSHOT 281
FIGURE 49 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT 284
FIGURE 50 BEIERSDORF AG: COMPANY SNAPSHOT 290
FIGURE 51 GLYCERYL GLUCOSIDE MARKET: RESEARCH DESIGN 316
FIGURE 52 KEY DATA FROM SECONDARY SOURCES 317
FIGURE 53 KEY DATA FROM PRIMARY SOURCES 318
FIGURE 54 INSIGHTS FROM INDUSTRY EXPERTS 319
FIGURE 55 BREAKDOWN OF PRIMARIES, BY COMPANY TYPE, DESIGNATION, AND REGION 319
FIGURE 56 GLYCERYL GLUCOSIDE MARKET: DEMAND-SIDE CALCULATION 321
FIGURE 57 GLYCERYL GLUCOSIDE MARKET SIZE ESTIMATION STEPS AND RESPECTIVE SOURCES: SUPPLY SIDE 322
FIGURE 58 GLYCERYL GLUCOSIDE MARKET: SUPPLY-SIDE ANALYSIS 323
FIGURE 59 DATA TRIANGULATION METHODOLOGY 324

---

---